Skip to main content
. 2019 Aug 29;17(3):1455. doi: 10.18549/PharmPract.2019.3.1455

Table 4. Referral recommendations depending on gender, age groups and municipality.

R0 R1 R2
N % 95% CI N % 95% CI N % 95% CI
Gender
Male (n=141) 530 37.8% 35.3%:40.4% 695 49.6% 47.0%:52.3% 176 12.6% 10.9%:14.4%
Female (n=4129) 1414 34.2% 32.8%:35.7% 2287 55.4% 53.9%:56.9% 428 10.4% 9.5%:11.3%
Age groups
< 50 yo (n=1913) 783 40.9% 38.7%:43.2% 949 49.6% 47.3%:51.9% 181 9.5% 8.2%:10.9%
50 – 69 yo (n=2278) 807 35.4% 33.5%:37.4% 1252 55.0% 52.9%:57.0% 219 9.6% 8.4%:10.9%
>70 yo (n=1339) 354 26.4% 24.1%:28.9% 781 58.3% 55.6%:61.0% 204 15.2% 13.4%:17.3%
Municipality
Rural (n=421) 120 28.5% 24.2%:33.1% 270 64.1% 59.3%:68.7% 31 7.4% 5.1%:10.3%
Urban (n=1306) 419 32.1% 29.6%:34.7% 715 54.7% 52.0%:57.5% 172 13.2% 11.4%:15.1%
Big city (n=3803) 1405 36.9% 35.4%:38.5% 1997 52.5% 50.9%:54.1% 401 10.5% 9.6%:9.6%
TOTAL 1944 35.2% 33.9%:36.4% 2982 53.9% 52.6%:55.2% 604 10.9% 10.1%:11.8%

R0: No risk factors. R1: Risk factor(s) detected: referral to general practitioner. R2: Self-reported suspicious lesions: urgent referral to physician.